Skip to main content
Top
Published in: Diabetologia 5/2007

01-05-2007 | Article

Low levels of glucose transporters and \( K^{ + }_{{ATP}} \) channels in human pancreatic beta cells early in development

Authors: C. C. Richardson, K. Hussain, P. M. Jones, S. Persaud, K. Löbner, A. Boehm, A. Clark, M. R. Christie

Published in: Diabetologia | Issue 5/2007

Login to get access

Abstract

Aims/hypothesis

Although cells expressing insulin are detected early in human fetal development, islets isolated from fetal pancreases show poor insulin secretory responses to glucose, which may be the result of deficient glucose sensing. We have used dual and triple immunolabelling of human fetal and adult pancreas sections to investigate the presence of proteins that participate in glucose sensing in the pancreatic beta cell, namely glucose transporter 1 (GLUT 1, also known as SLC2A1), glucose transporter 2 (GLUT2, also known as SLC2A2), glucokinase (GCK) and inwardly rectifying K+ channel (KIR6.2, also known as KCNJ11) and sulphonylurea receptor 1 (SUR1, also known as ABCC8) subunits of ATP-sensitive K+ channels (\( {\text{K}}^{ + }_{{{\text{ATP}}}} \) channels).

Materials and methods

Pancreases obtained with ethical approval from human fetuses from 11 to 36 weeks of gestation, from infants and from adults were formalin-fixed and embedded in paraffin. Sections were labelled with antibodies to proteins of interest. Co-production of antigens was examined by dual and triple immunolabelling.

Results

GLUT2 and \( {\text{K}}^{ + }_{{{\text{ATP}}}} \) channel labelling was detected in the 11-week pancreas, but largely within the pancreatic epithelium, whereas no labelling for GLUT1 was observed. From 15 weeks, GLUT1, GCK and \( {\text{K}}^{ + }_{{{\text{ATP}}}} \) channel labelling was detected in an increasing proportion of insulin-positive cells and epithelial labelling with \( {\text{K}}^{ + }_{{{\text{ATP}}}} \) channel antibodies diminished. GLUT2 was seen in the majority of beta cells only after 7 months of age.

Conclusions/interpretation

The results demonstrate that only a subpopulation of beta cells in the human fetal pancreas produce all key elements of the glucose-sensing apparatus, which may contribute to poor secretory responses in early life.
Literature
1.
go back to reference Otonkoski T, Andersson S, Knip M, Simell O (1988) Maturation of insulin response to glucose during human fetal and neonatal development. Studies with perifusion of pancreatic islet-like cell clusters. Diabetes 37:286–291PubMedCrossRef Otonkoski T, Andersson S, Knip M, Simell O (1988) Maturation of insulin response to glucose during human fetal and neonatal development. Studies with perifusion of pancreatic islet-like cell clusters. Diabetes 37:286–291PubMedCrossRef
2.
go back to reference Mally MI, Otonkoski T, Lopez AD, Hayek A (1994) Developmental gene expression in the human fetal pancreas. Pediatr Res 36:537–544PubMed Mally MI, Otonkoski T, Lopez AD, Hayek A (1994) Developmental gene expression in the human fetal pancreas. Pediatr Res 36:537–544PubMed
3.
go back to reference Weinhaus AJ, Tabiin MT, Poronnik P, Palma CA, Cook DI, Tuch BE (2003) Insulin secretagogues, but not glucose, stimulate an increase in [Ca2+]i in the fetal human and porcine β-cell. J Clin Endocrinol Metab 88:2753–2759PubMedCrossRef Weinhaus AJ, Tabiin MT, Poronnik P, Palma CA, Cook DI, Tuch BE (2003) Insulin secretagogues, but not glucose, stimulate an increase in [Ca2+]i in the fetal human and porcine β-cell. J Clin Endocrinol Metab 88:2753–2759PubMedCrossRef
4.
go back to reference Piper K, Brickwood S, Turnpenny LW et al (2004) Beta cell differentiation during early pancreas development. J Endocrinol 181:11–23PubMedCrossRef Piper K, Brickwood S, Turnpenny LW et al (2004) Beta cell differentiation during early pancreas development. J Endocrinol 181:11–23PubMedCrossRef
5.
go back to reference De Vos A, Heimberg H, Quartier E et al (1995) Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489–2495PubMedCrossRef De Vos A, Heimberg H, Quartier E et al (1995) Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489–2495PubMedCrossRef
6.
go back to reference Ferrer J, Benito C, Gomis R (1995) Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes 44:1369–1374PubMedCrossRef Ferrer J, Benito C, Gomis R (1995) Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes 44:1369–1374PubMedCrossRef
7.
go back to reference Suzuki M, Fujikara K, Kotake K, Inagaki N, Seino S, Takata K (1999) Immunolocalization of sulphonylurea receptor 1 in rat pancreas. Diabetologia 42:1204–1211PubMedCrossRef Suzuki M, Fujikara K, Kotake K, Inagaki N, Seino S, Takata K (1999) Immunolocalization of sulphonylurea receptor 1 in rat pancreas. Diabetologia 42:1204–1211PubMedCrossRef
8.
go back to reference Gromada J, Ma X, Hoy M et al (2004) ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1−/− mouse alpha-cells. Diabetes 53(Suppl 3):S181–S189PubMedCrossRef Gromada J, Ma X, Hoy M et al (2004) ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1−/− mouse alpha-cells. Diabetes 53(Suppl 3):S181–S189PubMedCrossRef
9.
go back to reference Quesada I, Nadal A, Soria B (1999) Different effects of tolbutamide and diazoxide in α-, β-, and δ-cells within intact islets of Langerhans. Diabetes 48:2390–2397PubMedCrossRef Quesada I, Nadal A, Soria B (1999) Different effects of tolbutamide and diazoxide in α-, β-, and δ-cells within intact islets of Langerhans. Diabetes 48:2390–2397PubMedCrossRef
10.
go back to reference Tiedge M, Lenzen S (1993) Differential regulation of glucokinase and GLUT2 glucose transporter gene expression in pancreas and liver of neonatal and 16 day old rats. Biochem Mol Biol Int 29:161–166PubMed Tiedge M, Lenzen S (1993) Differential regulation of glucokinase and GLUT2 glucose transporter gene expression in pancreas and liver of neonatal and 16 day old rats. Biochem Mol Biol Int 29:161–166PubMed
11.
go back to reference Garcia-Flores M, Zueco JA, Arenas J, Blazquez E (2002) Expression of glucose transporter-2, glucokinase and mitochondrial glycerol phosphate dehydrogenase in pancreatic islets during rat ontogenesis. Eur J Biochem 269:119–127PubMedCrossRef Garcia-Flores M, Zueco JA, Arenas J, Blazquez E (2002) Expression of glucose transporter-2, glucokinase and mitochondrial glycerol phosphate dehydrogenase in pancreatic islets during rat ontogenesis. Eur J Biochem 269:119–127PubMedCrossRef
12.
go back to reference Pang K, Mukonoweshuro C, Wong GG (1994) Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of the developing rat pancreas. Proc Natl Acad Sci U S A 91:9559–9563PubMedCrossRef Pang K, Mukonoweshuro C, Wong GG (1994) Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of the developing rat pancreas. Proc Natl Acad Sci U S A 91:9559–9563PubMedCrossRef
13.
go back to reference Bouwens L, Lu WG, De Krijger R (1997) Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 40:398–404PubMedCrossRef Bouwens L, Lu WG, De Krijger R (1997) Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 40:398–404PubMedCrossRef
15.
go back to reference Wang H, Gauthier B, Hagenfeldt-Johansson KA, Iezzi M, Wollheim CB (2002) Foxa2 (HNF3b) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release. J Biol Chem 277:17564–17570PubMedCrossRef Wang H, Gauthier B, Hagenfeldt-Johansson KA, Iezzi M, Wollheim CB (2002) Foxa2 (HNF3b) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release. J Biol Chem 277:17564–17570PubMedCrossRef
Metadata
Title
Low levels of glucose transporters and channels in human pancreatic beta cells early in development
Authors
C. C. Richardson
K. Hussain
P. M. Jones
S. Persaud
K. Löbner
A. Boehm
A. Clark
M. R. Christie
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0644-x

Other articles of this Issue 5/2007

Diabetologia 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.